Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory, with Excess of Blasts

Explore clinical trials studying Anemia, Refractory, with Excess of Blasts. Study availability and eligibility vary by location and protocol.

244 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Refractory, with Excess of Blasts trial results

Completed

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

NCT00045305

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Tufts-NEMC Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View Trial Details
Completed

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

NCT03886831

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Anemia, +39 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCSF Precision Cancer Medicine Building San Francisco, California, United States
  • Christiana Care Health Services, Christiana Hospital Newark, Delaware, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
View all 23 locations
View Trial Details
Completed

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

NCT00354120

Conditions
Acute Myeloblastic Leukemia, Anemia, Anemia, Refractory, +28 more
Locations
  • Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy
  • Divisione Ematologia - Ospedale "SS. Antonio, Biagio e Cesare Arrigo" Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
  • Divisione di Ematologia - Ospedali Riuniti Bergamo Bergamo, Italy
View all 22 locations
View Trial Details
Completed

Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

NCT02345850

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 28 locations
View Trial Details
Completed

Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy

NCT01956799

Conditions
Anemia, Anemia, Aplastic, Anemia, Refractory, +11 more
Locations
  • Ematologia, AO SS. Antonio e Biagio Alessandria, AL, Italy
  • Clinica di Ematologia, AOU Ospedale di Torrette Ancona, AN, Italy
  • Ematologia con trapianto, AOU Policlinico di Bari Bari, BA, Italy
  • Istituto di Ematologia e Oncologia Medica, Policlinico S.Orsola Bologna, BO, Italy
View all 20 locations
View Trial Details
Completed

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

NCT01168219

Conditions
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, +34 more
Locations
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 17 locations
View Trial Details
Completed

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

NCT01807091

Conditions
Adult Acute Myeloid Leukemia, Adult Myelodysplastic Syndrome, Anemia, +11 more
Locations
  • Bozeman Deaconess Hospital Bozeman, Montana, United States
  • Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States
  • EvergreenHealth Medical Center Kirkland, Washington, United States
  • Skagit Valley Hospital Mount Vernon, Washington, United States
View Trial Details
Completed

Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome

NCT00017550

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +4 more
Locations
  • Washington Cancer Institute Washington D.C., District of Columbia, United States
  • University of Florida Health Science Center Gainesville, Florida, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 28 locations
View Trial Details

Related conditions